Mac-1 Directly Binds to the Endothelial Protein C-Receptor: A Link between the Protein C Anticoagulant Pathway and Inflammation?

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Fink, Katrin ^a   Busch, Hans Jörg ^b   Bourgeois, Natascha ^a   Schwarz, Meike ^a   Wolf, Dennis ^a   Zirlik, Andreas ^a   Peter, Karlheinz ^c   Bode, Christoph ^a   von zur Muhlen, Constantin ^a  

^a UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; DROTRECOGIN; ENDOTHELIAL PROTEIN C RECEPTOR; MONOCLONAL ANTIBODY; PROTEIN C;

ANIMAL CELL; ANTICOAGULATION; ARTICLE; BINDING KINETICS; CELL ADHESION; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR BINDING;

ANTIGENS, CD; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; INFLAMMATION; MACROPHAGE-1 ANTIGEN; MONOCYTES; PROTEIN BINDING; PROTEIN C; RECEPTORS, CELL SURFACE;

EID: 84873605287     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053103     Document Type: Article

References (29)

1. Fukudome K, Esmon CT, (1995) Molecular cloning and expression of murine and bovine endothelial cell protein C/activated protein C receptor (EPCR): The structural and functional conservation in human, bovine, and murine EPCR. J Biol Chem 270: 5571-5577.
2. Laszik Z, Mitro A, Taylor FB Jr, Ferrell G, Esmon CT, (1997) Human protein C receptor is present primarily on endothelium of large blood vessels: Implications for the control of the protein C pathway. Circulation 96: 3633-3640.
3. Esmon CT, (2003) The Protein C Pathway. Chest 124: 26S-32S.
4. Nicolaes GA, Dahlbäck B, (2002) Factor V and thrombotic disease: description of a janus-faced protein. Arterioscler Thromb Vasc Biol 22: 530-538.
5. Opal SM, (2000) Phylogenetic and functional relationships between coagulation and the innate immune response. Crit Care Med 28: S77-S80.
6. Kurosawa S, Stearns-Kurosawa DJ, Hidari N, Esmon CT, (1997) Identification of functional endothelial protein C receptor in human plasma. J Clin. Invest 100: 411.
7. Kurosawa S, Esmon CT, Stearns-Kurosawa DJ, (2000) The soluble endothelial protein C receptor binds to activated neutrophils: involvement of proteinase-3 and CD11b/CD18. J Immunol 165: 4697-4703.
8. Kurosawa S, Stearns-Kurosawa DJ, Carson CW, D'Angelo A, Della Valle P, et al. (1998) Plasma levels of endothelial cell protein C receptor are elevated in patients with sepsis and systemic lupus erythematosus: lack of correlation with thrombomodulin suggests involvement of different pathological processes. Blood 91: 725.
9. Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, Ferrell GL, Esmon CT, (1996) The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci 93: 10212.
10. Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW, (2001) Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 276: 11199-11203.
11. Cheng T, Liu D, Griffin JH, Fernández JA, Castellino F, et al. (2003) Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med 9: 338-42.
12. Mizutani A, Okajima K, Uchiba M, Noguchi T, (2000) Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 95: 3781-3787.
13. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699-709.
14. Springer TA, (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314.
15. Xia Y, Vetvicka V, Yan J, Hanikyrova M, Mayadas T, et al. (1999) The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. J Immunol 162: 2281-90.
16. Altieri DC, Agbanyo FR, Plescia J, Ginsberg MH, Edgington TS, et al. (1990) A unique recognition site mediates the interaction of fibrinogen with the leukocyte integrin Mac-1 (CD11b/Cd18). J Biol Chem 265: 12119-12122.
17. Schwarz M, Nordt T, Bode C, Peter K, (2002) The GP IIb/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1 (CD11b/CD18, aMß2). Thromb Res 107: 121-128.
18. Diamond MS, Alon R, Parkos CA, Quinn MT, Springer TA, (1995) Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD1). J Cell Biol 130: 1473-1482.
19. Peter K, Schwarz M, Conradt C, Nordt T, Moser M, et al. (1999) Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18). Circulation 100: 1533-1539.
20. Diamond MS, Staunton DE, Marlin SD, Springer TA, (1991) Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 65: 961-971.
21. Schuler P, Assefa D, Ylänne J, Basler N, Olschewski M, et al. (2003) Adhesion of monocytes to medical steel as used for vascular stents is mediated by the integrin receptor Mac-1 (CD11b/CD18; alphaM beta2) and can be inhibited by semiconductor coating. Cell Commun Adhes 10: 17-26.
22. Eisenhardt SU, Schwarz M, Schallner N, Soosairajah J, Bassler N, et al. (2007) Generation of activation-specific human anti-alphaMbeta2 single-chain antibodies as potential diagnostic tools and therapeutic agents. Blood 109: 3521-3528.
23. Kanse SM, Matz RL, Preissner KT, Peter K, (2004) Promotion of leukocyte adhesion by a novel interaction between vitronectin and the beta2 integrin Mac-1 (alphaM beta2, CD11b/CD18). Arterioscler Thromb Vasc Biol 24: 2251-2256.
24. Xu J, Qu D, Esmon NL, Esmon CT, (1999) Metalloproteolytic release of endothelial cell protein C receptor. J Biol Chem 275: 6038-6044.
25. Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, et al. (1996) Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 87: 642-647.
26. Taylor FB Jr, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, et al. (1987) Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 79: 918-925.
27. Franscini N, Bachli EB, Blau N, Leikauf MS, Schaffner A, et al. (2004) Gene expression profiling of inflamed human endothelial cells and influence of activated protein C. Circulation. 110: 2903-2909.
28. Grinnell BW, Joyce D, (2001) Recombinant human activated protein C: a system modulator of vascular function for treatment of severe sepsis. Crit Care Med Suppl (53-0):: 60-61.
29. Scaldaferri F, Sans M, Vetrano S, Graziani C, De Cristofaro R, et al. (2007) Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease. J Clin Invest 117: 1951-1960.